Vivos Therapeutics Financial Overview
Vivos Therapeutics's market cap is currently $18.61M. The company's EPS TTM is $-0.49; its P/E ratio is -1.02; Vivos Therapeutics is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
